Hematotoxicity Testing by Cell Clonogenic Assay in Drug Development and Preclinical Trials

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|11|8|1055-1065

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.11, Iss.8, 2005-03, pp. : 1055-1065

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Application of Lipidomics to Assess Lipogenesis in Drug Development and Pre-Clinical Trials

By  

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 5, 2012-04 ,pp. : 736-745

Bentham Science Publishers

Access to resources Recommend Favorite

Metabonomics in preclinical drug development

By Robertson Donald G   Reily Michael D   Baker J David  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 1, Iss. 3, 2005-10 ,pp. : 363-376

Informa Healthcare

Access to resources Recommend Favorite

A Review of: "Preclinical Drug Development"

By Keep Marcus F.  

Drug Development and Industrial Pharmacy, Vol. 33, Iss. 4, 2007-04 ,pp. : 493-493

Informa Healthcare

Access to resources Recommend Favorite

Preclinical drug development for childhood cancer

By Moreno Lucas   Chesler Louis   Hargrave Darren   Eccles Suzanne A   Pearson Andrew DJ  

Expert Opinion on Drug Discovery, Vol. 6, Iss. 1, 2011-01 ,pp. : 49-64

Informa Healthcare

Access to resources Recommend Favorite

In Vivo Models of Childhood Leukemia for Preclinical Drug Testing

By  

Current Drug Targets, Vol. 8, Iss. 6, 2007-06 ,pp. : 773-783

Bentham Science Publishers

Access to resources Recommend Favorite